Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

827
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
827
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

926
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
926
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

631
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
631
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

1.8K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.8K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

2.3K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Organizational structures of dialysis access care and the role of interventional nephrology: a Germany-wide survey.

BMC nephrology·2026
Same author

Machine Learning for Monoclonal Gammopathies of Renal Significance Risk Stratification Using Clinical and Pathology Data.

Kidney international reports·2025
Same author

Alpha-1 antitrypsin inhibits pertussis toxin.

The Journal of biological chemistry·2024
Same author

Placement of tunnelled haemodialysis catheters-interventional standard.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2024
Same author

Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS- real-world data.

BMC nephrology·2024
Same author

Challenges Faced by Solid Organ Transplant Recipients During the COVID-19 Pandemic in France: Historical Insights and Key Takeaways.

Transplantation·2024

Related Experiment Video

Updated: May 3, 2026

Murine Kidney Transplant Technique
08:58

Murine Kidney Transplant Technique

Published on: October 20, 2015

16.6K

Delayed kidney graft function: from mechanism to translation.

Bernd Schröppel1, Christophe Legendre2

  • 1Division of Nephrology, University of Ulm, Ulm, Germany.

Kidney International
|February 14, 2014
PubMed
Summary

Delayed graft function after kidney transplant, often due to ischemia and reperfusion injury, impacts long-term survival. Understanding its complex mechanisms is key to developing new therapies for better patient outcomes.

More Related Videos

Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

20.4K
Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
09:00

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

6.9K

Related Experiment Videos

Last Updated: May 3, 2026

Murine Kidney Transplant Technique
08:58

Murine Kidney Transplant Technique

Published on: October 20, 2015

16.6K
Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

20.4K
Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
09:00

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

6.9K

Area of Science:

  • Nephrology
  • Transplantation immunology
  • Regenerative medicine

Background:

  • Delayed graft function (DGF) complicates up to 50% of kidney transplants, primarily due to ischemia and reperfusion injury.
  • DGF is linked to acute complications, prolonged hospitalization, chronic allograft nephropathy, and reduced allograft survival.
  • The multifactorial nature of DGF, involving both donor and recipient factors, presents significant challenges in understanding its underlying mechanisms.

Purpose of the Study:

  • To explore the complex mechanisms contributing to delayed graft function following kidney transplantation.
  • To review current and emerging therapeutic strategies aimed at mitigating DGF and improving transplant outcomes.
  • To highlight the challenges in translating novel DGF therapies from preclinical research to clinical application.

Main Methods:

  • Review of existing literature on the pathophysiology of ischemia and reperfusion injury in kidney transplantation.
  • Analysis of current therapeutic approaches targeting inflammation, cell death, and signaling pathways involved in DGF.
  • Discussion of challenges and future directions for clinical trial design in DGF research.

Main Results:

  • Delayed graft function involves a complex interplay of hypoxic/ischemic injury and altered repair mechanisms.
  • Emerging therapies focus on suppressing immune cell infiltration, limiting cell death, and interrupting necrosis signaling.
  • Significant hurdles remain in translating promising preclinical findings into effective clinical treatments for DGF.

Conclusions:

  • Addressing the complex pathophysiology of DGF is crucial for improving kidney transplant success.
  • Novel therapeutic targets show promise but require further validation and clinical translation.
  • Identifying at-risk organs and establishing clear endpoints are essential for advancing interventional trials in DGF.